Image
Image
Award-winning aesthetic devices for leading Australia & New Zealand clinics.

S a y  
h e l l o  
t o  
t h e  
f u t u r e  
o f  
a e s t h e t i c s .

S e e   o u r   d e v i c e s   i n   a c t i o n

Image
Image
Image
Image
Image
Image
OUR MISSION
Empowering practitioners in Australia & New Zealand with award-winning aesthetic devices.
Image
Image

M e e t   o u r   a w a r d - w i n n i n g   d e v i c e s

SUPPORT

3 6 0 °   S u p p o r t

Including after-sales support, training, servicing and ongoing events, included with all Avaderm® Devices, across Australia & New Zealand.
Our brands have been featured in
Image
Image
Image

All devices ARTG-Listed and MedSafe Approved. A l l d e v i c e s A R T G - L i s t e d a n d M e d S a f e A p p r o v e d .

Only the best quality and compliant devices.

EDUCATION & SUPPORT

L i f e t i m e   C l i n i c a l   T r a i n i n g

Included complimentary with all Avaderm® Devices, across Australia & New Zealand. T&C's apply.

News & Events

T-Lab® Regenerative Seminar 2.0 Is Coming to Sydney - Nov 2026
After Brisbane sold out, we knew we couldn't just repeat ourselves. So when we started planning the next chapter of the T-Lab® Regenerative Seminar, we asked a simple question: how do you follow a sold-out night? You raise the stakes. This November, T-Lab® Regenerative Seminar 2.0 arrives in Sydney — and we're thrilled to confirm it's being held at the Art Gallery of New South Wales, one of the city's most iconic settings and a fitting stage for a day dedicated to the future of regenerative aesthetics.   Why We're Doing This Again Brisbane wasn't just a full room — it was proof that our T-Lab® clinics are hungry for more than product updates. They want the science, the technique, and the strategy that turns a great treatment into a great business. Regenerative aesthetics is moving fast, and the clinics leading the category are the ones staying closest to what's next. Seminar 2.0 is our answer to that appetite. Bigger stage, sharper content, same exclusive room.   What's on the Agenda Across the day, expect a program built for practitioners who want to lead, not follow: Incredible keynote speakers bringing global perspective on where regenerative treatments are headed next. Brand-new product launches, unveiled first to the room before anywhere else. Business insights designed to help you translate clinical excellence into a thriving, well-run clinic. Morning tea, lunch and afternoon tea are included throughout the day.   Who Gets a Seat This one is exclusively for clinics with the T-Lab®  System. It's not a public event, and it's not one we're opening wider — the value of the room comes from who's in it. If that's you, this is your invitation. How to Secure Your Spot Spaces are limited, and after Brisbane, we expect this one to move quickly. Contact our team directly to lock in your tickets before they're gone.
T-Lab® Ranked #1 Autologous System at IMCAS World Congress 2025
At the prestigious IMCAS World Congress 2025, a comparative study evaluating seven leading autologous concentration systems was presented by Prof. Pietro Gentile, Plastic Surgeon, Italy, and Prof. Jeremy Magalon, Pharmacologist, France. The presentation, titled 'PRODUCT ANALYSIS > comparative non-commercial study on a selection of products or devices currently available on the market', compared how these systems performed. T-Lab® achieved the highest rankings across the key performance metrics, including platelet dose, platelet recovery rate and overall system effectiveness. Top Results in Concentration and Recovery The study analysed seven of the world's leading systems against criteria that matter in regenerative and aesthetic practice. T-Lab® ranked first with: #1 Platelet Dose: 4.6 billion platelets, the highest of all systems tested. #1 Platelet Recovery Rate: 90.1%, showing highly efficient extraction and preservation. #1 Overall System Ranking: Above 90% in every evaluated category. Why These Findings Matter Autologous concentration systems are widely used in regenerative and aesthetic practice, so system performance is an important consideration for practitioners. The findings presented at IMCAS World Congress 2025 support T-Lab®'s reputation as a highly effective and reliable system. A higher platelet dose and recovery rate mean clinicians can prepare a more concentrated preparation with minimal loss from each draw. Setting the Standard in Regenerative Technology This recognition reflects years of dedicated research and innovation in autologous regenerative technology, and gives medical professionals confidence in the system they choose for their practice. As demand for regenerative treatments grows, T-Lab® remains a leading choice for clinics worldwide, offering strong efficiency and consistency. For health professionals looking to elevate their regenerative offerings, T-Lab® delivers leading technology backed by independent comparative data. For more details on the study presented at IMCAS World Congress 2025, visit: IMCAS 2025 Session.